Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D. Gillmore, Jonathan C. Fox, Karen Chiswell et al.|New England Journal of Medicine|2024Cited by 453
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, Mathew S. Maurer, John L. Berk et al.|New England Journal of Medicine|2024Cited by 356
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac AmyloidosisRichard K. Cheng, Mathew S. Maurer, Wayne C. Levy et al.|JACC CardioOncology|2020Cited by 139
Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart DiseasePierre Elias, Adler Perotte, Timothy J. Poterucha et al.|Journal of the American College of Cardiology|2022Cited by 139
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m PyrophosphateTimothy J. Poterucha, Mathew S. Maurer, Pierre Elias et al.|JACC. Cardiovascular imaging|2020Cited by 103